Luxco 2017 Irrevocable Trust dated June 19, 2017
CIK: 0001853907
Luxco 2017 Irrevocable Trust dated June 19, 2017's purchase track record
Luxco 2017 Irrevocable Trust dated June 19, 2017 has only 2 open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 8/8/2022 | MGPI | $551K | +3.4% | -10.6% | -0.7% |
| 6/15/2022 | MGPI | $467K | +21.3% | +21.7% | +5.4% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| MGPI | ▼ Sell | Open Market | 1,157 | $118K | 6/12/2023 | View on chart |
| MGPI | ▼ Sell | Open Market | 6,843 | $691K | 6/12/2023 | View on chart |
| MGPI | ▲ Buy | Open Market | 5,000 | $551K | 8/8/2022 | View on chart |
| MGPI | ▲ Buy | Open Market | 3,890 | $363K | 6/15/2022 | View on chart |
| MGPI | ▲ Buy | Open Market | 1,110 | $104K | 6/15/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 29, 2026
MGP Ingredients Cited as Potential Value Pick in Distillery Sector
A recent analysis highlights MGP Ingredients as a potentially undervalued option within the currently depressed distillery sector. The stock is trading near its 52-week low, with an RSI of 22.5 indicating oversold conditions. Analysts maintain an average price target of $27.80, which is significantly higher than the current support level of $17.57.
MGP Ingredients Cited as Potential Value Pick in Distillery Sector. A recent analysis highlights MGP Ingredients as a potentially undervalued option within the currently depressed distillery sector. The stock is trading near its 52-week low, with an RSI of 22.5 indicating oversold conditions. Analysts maintain an average price target of $27.80, which is significantly higher than the current support level of $17.57.